# OnCo record tasquinimod-10tasq10 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/tasquinimod-10tasq10/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "tasquinimod-10tasq10", "NCT01234311" ;
  schema:name "10TASQ10"@en ;
  schema:alternateName "10TASQ10"@en, "tasquinimod phase 3"@en ;
  schema:description "A drug aimed at the tissue around the tumour delayed progression on scans by two and a half months, and the men who took it lived, if anything, slightly less long."@en ;
  schema:url <https://onco.cc/trials/tasquinimod-10tasq10/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01234311>, <https://doi.org/10.1200/JCO.2016.66.9697> ;
  onco:status "negative" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/antiangiogenic/> ;
  onco:drugs <https://onco.cc/drugs/tasquinimod/> ;
  onco:companies <https://onco.cc/companies/active-biotech/>, <https://onco.cc/companies/ipsen/> ;
  onco:terms <https://onco.cc/terms/castration-resistance/>, <https://onco.cc/terms/bone-metastases/> ;
  onco:trials <https://onco.cc/trials/elm-pc-4-orteronel/> .